tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Heart Failure D006333 36 associated lipids
Angioedema D000799 6 associated lipids
Fractures, Spontaneous D005598 4 associated lipids
Hydronephrosis D006869 4 associated lipids
Trypanosomiasis D014352 5 associated lipids
Alopecia D000505 14 associated lipids
Liver Diseases D008107 31 associated lipids
Corneal Diseases D003316 13 associated lipids
Testicular Diseases D013733 15 associated lipids
Facial Dermatoses D005148 7 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Acne Vulgaris D000152 35 associated lipids
Urination Disorders D014555 9 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Anemia, Hemolytic D000743 4 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Vision Disorders D014786 10 associated lipids
Multiple Myeloma D009101 13 associated lipids
Osteochondrodysplasias D010009 3 associated lipids
Melanoma D008545 69 associated lipids
Hematologic Diseases D006402 3 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Osteoporosis D010024 12 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Kidney Diseases D007674 29 associated lipids
Hematuria D006417 13 associated lipids
Weight Gain D015430 101 associated lipids
Brain Diseases D001927 27 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Infection D007239 6 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Bone Diseases D001847 4 associated lipids
Leukemia P388 D007941 43 associated lipids
Ulcer D014456 16 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Obesity D009765 29 associated lipids
Thrombosis D013927 49 associated lipids
Bradycardia D001919 13 associated lipids
Hemorrhage D006470 15 associated lipids
Proteinuria D011507 30 associated lipids
Lymphoma D008223 18 associated lipids
Femur Head Necrosis D005271 5 associated lipids
Alzheimer Disease D000544 76 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Eye Diseases D005128 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Kojima R et al. Release mechanisms of tacrolimus-loaded PLGA and PLA microspheres and immunosuppressive effects of the microspheres in a rat heart transplantation model. 2015 Int J Pharm pmid:26160668
Meng QH et al. Falsely elevated tacrolimus concentrations on the Dimension Xpand. 2015 Clin. Biochem. pmid:26160209
Fischer L et al. Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study. 2015 Transplantation pmid:26151607
Spolidorio LC et al. The long-term administration of calcineurin inhibitors decreases antioxidant enzyme activity in the rat parotid and submandibular salivary glands. 2015 Life Sci. pmid:26006038
Shamsudin N et al. Objective assessment of vitiligo with a computerised digital imaging analysis system. 2015 Australas. J. Dermatol. pmid:25367709
Ali H et al. Mycophenolate mofetil-based salvage as acute GVHD prophylaxis after early discontinuation of tacrolimus and/or sirolimus. 2015 Bone Marrow Transplant. pmid:25365064
Lee SC et al. Calcineurin orchestrates dimorphic transitions, antifungal drug responses and host-pathogen interactions of the pathogenic mucoralean fungus Mucor circinelloides. 2015 Mol. Microbiol. pmid:26010100
Kedzierska K et al. The effect of immunosuppressive therapy on renal cell apoptosis in native rat kidneys. 2015 Histol. Histopathol. pmid:25029518
Menotta M et al. Label-free quantification of Tacrolimus in biological samples by atomic force microscopy. 2015 Anal. Chim. Acta pmid:26073814
Sato K et al. Late onset of progressive speech impairment due to tacrolimus-associated leukoencephalopathy after kidney transplantation. 2015 Int Urol Nephrol pmid:26071870
Pulk RA et al. Multigene predictors of tacrolimus exposure in kidney transplant recipients. 2015 Pharmacogenomics pmid:26067485
Koreth J et al. A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial. 2015 Biol. Blood Marrow Transplant. pmid:26055298
Pardi C and Oltean M An unusual case of red blood cell immunisation following liver transplantation. 2015 Blood Transfus pmid:26057497
Parody R et al. GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT. 2015 Bone Marrow Transplant. pmid:25310306
Hollis IB et al. Medication management of cardiac allograft vasculopathy after heart transplantation. 2015 Pharmacotherapy pmid:26011142
Chen YB et al. Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma. 2015 Biol. Blood Marrow Transplant. pmid:26009261
Ribero S et al. Efficacy of topical tacrolimus for oral lichen planus: real-life experience in a retrospective cohort of patients with a review of the literature. 2015 J Eur Acad Dermatol Venereol pmid:25308924
Revollo J Update on the clinical utility of once-daily tacrolimus in the management of transplantation. 2015 Drug Des Devel Ther pmid:26005334
Qasim W et al. Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient. 2015 J. Hepatol. pmid:25308176
Cortes X et al. Successful use of infliximab and tacrolimus in a patient with Crohn's disease. 2015 Int J Clin Pharmacol Ther pmid:25997551
Chan TM Treatment of severe lupus nephritis: the new horizon. 2015 Nat Rev Nephrol pmid:25421826
Andreu F et al. Development of a population PK model of tacrolimus for adaptive dosage control in stable kidney transplant patients. 2015 Ther Drug Monit pmid:25254416
Fussner LA et al. Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk. 2015 Liver Transpl. pmid:25880971
Banhara PB et al. Tubular dysfunction in renal transplant patients using sirolimus or tacrolimus. 2015 Clin. Nephrol. pmid:25943142
Abuabara K et al. Atopic dermatitis disease control and age: A cohort study. 2015 J. Allergy Clin. Immunol. pmid:25935107
Bonanni A et al. Low-dose ofatumumab for rituximab-resistant nephrotic syndrome. 2015 BMJ Case Rep pmid:26376698
Clark SL et al. Making every drop count for pediatric kidney transplant patients. 2015 Hosp Pediatr pmid:25934814
de Sandes-Freitas TV et al. Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus. 2015 Transplantation pmid:25929604
Cheng S and Rodier F Manipulating senescence in health and disease: emerging tools. 2015 Cell Cycle pmid:25928330
Falloon K et al. Characterization of the FKBP12-Encoding Genes in Aspergillus fumigatus. 2015 PLoS ONE pmid:26366742
Ikitimur B et al. Long-Term Impact of Different Immunosuppressive Drugs on QT and PR Intervals in Renal Transplant Patients. 2015 Ann Noninvasive Electrocardiol pmid:25367596
Ganetsky A et al. Lack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients. 2015 J. Antimicrob. Chemother. pmid:25881619
Goldthorpe H et al. Occlusive lung arterial lesions in endothelial-targeted, fas-induced apoptosis transgenic mice. 2015 Am. J. Respir. Cell Mol. Biol. pmid:25879383
Liang GB et al. Impact of immunosuppressive agents on the expression of indoleamine 2,3-dioxygenase, heme oxygenase-1 and interleukin-7 in mesangial cells. 2015 Mol Med Rep pmid:25936769
Chapron B et al. Reversible, time-dependent inhibition of CYP3A-mediated metabolism of midazolam and tacrolimus by telaprevir in human liver microsomes. 2015 J Pharm Pharm Sci pmid:25877445
Nashan B et al. Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. 2015 Trials pmid:25873064
Ramachandran R et al. Chronic nephrotoxicity limits successful use of Tacrolimus in the management of adult steroid-dependent minimal change disease. 2015 Nephrology (Carlton) pmid:25872662
Zijlstra LE et al. [Heart transplantation in the 21st century in Netherlands: improved survival in the last decade]. 2015 Ned Tijdschr Geneeskd pmid:26648576
Ott M et al. Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway. 2015 Glia pmid:25132599
Abudou M et al. Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty. 2015 Cochrane Database Syst Rev pmid:26313245
Söderlund C and Rådegran G Immunosuppressive therapies after heart transplantation--The balance between under- and over-immunosuppression. 2015 Transplant Rev (Orlando) pmid:25812489
Zegarska J et al. Mycophenolic Acid Metabolites Acyl-Glucuronide and Glucoside Affect the Occurrence of Infectious Complications and Bone Marrow Dysfunction in Liver Transplant Recipients. 2015 Ann. Transplant. pmid:26313036
Naito T et al. ABCB1 genetic variant and its associated tacrolimus pharmacokinetics affect renal function in patients with rheumatoid arthritis. 2015 Clin. Chim. Acta pmid:25817604
Lee JR et al. Gut microbiota and tacrolimus dosing in kidney transplantation. 2015 PLoS ONE pmid:25815766
Dave V et al. Managing psychosis in a renal transplant recipient with bipolar affective disorder and allograft rejection. 2015 Nephrology (Carlton) pmid:25807849
Hlavaty KA et al. Cellular and molecular targeting for nanotherapeutics in transplantation tolerance. 2015 Clin. Immunol. pmid:25805659
Honda Y et al. Disseminated Mycobacterium mantenii infection with multiple purulent cutaneous lesions. 2015 Acta Derm. Venereol. pmid:25881714
Stevens RB et al. A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes. 2015 Transplantation pmid:25083614
La Placa M et al. Disfiguring papular sarcoidosis of the face: dramatic improvement with pimecrolimus. 2015 J Eur Acad Dermatol Venereol pmid:25073484
Mlih M et al. Na(+)/H (+) exchanger isoform 1 induced osteopontin expression in cardiomyocytes involves NFAT3/Gata4. 2015 Mol. Cell. Biochem. pmid:25758355
Ravaioli M et al. Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial. 2015 Transplantation pmid:25757214
Bis DM et al. Characterization of the nocardiopsin biosynthetic gene cluster reveals similarities to and differences from the rapamycin and FK-506 pathways. 2015 Chembiochem pmid:25755076
Rahman Z et al. Comparison of X-ray powder diffraction and solid-state nuclear magnetic resonance in estimating crystalline fraction of tacrolimus in sustained-release amorphous solid dispersion and development of discriminating dissolution method. 2015 J Pharm Sci pmid:25753829
Garritsen FM et al. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres. 2015 J Eur Acad Dermatol Venereol pmid:25752497
Devine SM et al. Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502. 2015 J. Clin. Oncol. pmid:26527780
Qian G et al. Successful treatment of recalcitrant granulomatous rosacea with oral thalidomide and topical pimecrolimus. 2015 J. Dermatol. pmid:25753523
Pennington CA et al. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients. 2015 Pharmacotherapy pmid:26234282
Zhu L et al. Adrenergic stimulation sensitizes TRPV1 through upregulation of cystathionine β-synthetase in a rat model of visceral hypersensitivity. 2015 Sci Rep pmid:26527188
Tachibana T et al. Successful Engraftment and Durable Graft-versus-host Disease Control with Haploidentical Peripheral Blood and a Short-term Conditioning Regimen for Primary Graft Failure. 2015 Intern. Med. pmid:26521905
Vanhove T et al. Response to 'Tacrolimus pharmacokinetics after kidney transplantation--Influence of changes in haematocrit and steroid dose'. 2015 Br J Clin Pharmacol pmid:26235051
Hanifin JM A Reassuring Rejoinder Against Malignant Influences of Topical Calcineurin Use in Children. 2015 JAMA Dermatol pmid:25692944
Margolis DJ et al. Association Between Malignancy and Topical Use of Pimecrolimus. 2015 JAMA Dermatol pmid:25692459
Shuker N et al. Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management. 2015 Transplant Rev (Orlando) pmid:25687818
Fan DM et al. Successful ABO-incompatible living-related intestinal transplantation: a 2-year follow-up. 2015 Am. J. Transplant. pmid:25808777
Kawakami K et al. Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis. 2015 World J. Gastroenterol. pmid:25684955
Stevens RB et al. A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology. 2015 PLoS ONE pmid:26465152
Cai W et al. Limited sampling strategy for predicting area under the concentration-time curve for mycophenolic Acid in Chinese adults receiving mycophenolate mofetil and tacrolimus early after renal transplantation. 2015 Ther Drug Monit pmid:25525761
Matsushima M et al. [A case of anti-PL7 antibody positive myositis and a clinical and pathological review of the anti-synthetase syndrome]. 2015 Rinsho Shinkeigaku pmid:26458569
Almeida-Corrêa S et al. Calcineurin inhibition blocks within-, but not between-session fear extinction in mice. 2015 Learn. Mem. pmid:25691516
Leneghan D and Bell A Immunophilin-protein interactions in Plasmodium falciparum. 2015 Parasitology pmid:26156578
Detroyer D et al. Resolution of diffuse skin and systemic Kaposi's sarcoma in a renal transplant recipient after introduction of everolimus: a case report. 2015 Transpl Infect Dis pmid:25645490
Luo X et al. Evaluation of 6β-Hydroxycortisol and 6β-Hydroxycortisone as Biomarkers for Cytochrome P450 3A Activity: Insight into Their Predictive Value for Estimating Oral Immunosuppressant Metabolism. 2015 J Pharm Sci pmid:26150050
Chen QJ et al. Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients. 2015 Ren Fail pmid:25644968
Herbst S et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. 2015 EMBO Mol Med pmid:25637383
Cuellar-Rodriguez J et al. Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency. 2015 Biol. Blood Marrow Transplant. pmid:25636378
Joneja U and Uppal G Pseudo-Pelger-Huët anomaly in a patient on tacrolimus. 2015 Blood pmid:26371350
Ustundag UV et al. The effects of tacrolimus on the activity and expression of tissue factor in the rat ovary with ischemia-reperfusion induced injury. 2015 Reprod Biol pmid:26370456
Gao L and Sun Y In vitro interactions of antifungal agents and tacrolimus against Aspergillus biofilms. 2015 Antimicrob. Agents Chemother. pmid:26303797
Kawahara T et al. Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1. 2015 Oncotarget pmid:25638160
Tohme FA et al. Conversion to a sirolimus-based regimen is associated with lower incidence of BK viremia in low-risk kidney transplant recipients. 2015 Transpl Infect Dis pmid:25582442
Dagher M et al. Overweight, central obesity, and cardiometabolic risk factors in pediatric liver transplantation. 2015 Pediatr Transplant pmid:25581506
Kita A et al. Imp2, the PSTPIP homolog in fission yeast, affects sensitivity to the immunosuppressant FK506 and membrane trafficking in fission yeast. 2015 Biochem. Biophys. Res. Commun. pmid:25580011
Cortina G et al. De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus. 2015 Pediatr. Nephrol. pmid:25577332
Annunziato RA et al. Can transition to adult care for transplant recipients be improved by intensified services while patients are still in pediatrics? 2015 Prog Transplant pmid:26308783
Pape E et al. Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus: Practical Considerations. 2015 Transplantation pmid:26308424
Ruiz J et al. Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation. 2015 Int J Mol Sci pmid:26307985
Kurita T et al. The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis. 2015 Rheumatology (Oxford) pmid:24764266
Cavalié M et al. Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study. 2015 J. Invest. Dermatol. pmid:25521460
Reddy YN et al. Is there a genetic predisposition to new-onset diabetes after kidney transplantation? 2015 Saudi J Kidney Dis Transpl pmid:26586047
Yu Y et al. Investigation into the interchangeability of generic formulations using immunosuppressants and a broad selection of medicines. 2015 Eur. J. Clin. Pharmacol. pmid:26062932
Millner L et al. A clinical approach to solving discrepancies in therapeutic drug monitoring results for patients on sirolimus or tacrolimus: Towards personalized medicine, immunosuppression and pharmacogenomics. 2015 Clin. Chim. Acta pmid:26232156
Tornatore KM et al. Influence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipients. 2015 Clin Pharmacokinet pmid:25511793
Li JL et al. Interactive effects of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on tracrolimus trough concentrations in early postrenal transplant recipients. 2015 Pharmacogenomics pmid:26228923
Zhu LQ et al. Posterior reversible encephalopathy syndrome and graft-versus-host disease after liver transplantation: a case report and review of the literature. 2015 Int J Clin Pharmacol Ther pmid:26227100
Zhang JJ et al. The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients. 2015 Int J Clin Pharmacol Ther pmid:26227094
Namvaran F et al. The Effect of Tacrolimus on Reactive Oxygen Species and Total Antioxidant Status in Pancreatic Beta Cell Line. 2015 Exp Clin Transplant pmid:25431882
Li YX and Dijkers PF Specific calcineurin isoforms are involved in Drosophila toll immune signaling. 2015 J. Immunol. pmid:25429067
Allison SJ Lupus nephritis: Multitarget induction therapy for LN. 2015 Nat Rev Nephrol pmid:25421833
Tan ES et al. Effective treatment of scrotal lichen simplex chronicus with 0.1% tacrolimus ointment: an observational study. 2015 J Eur Acad Dermatol Venereol pmid:24666218
Takeuchi S et al. Pruritus of patients with atopic dermatitis in daily life and their experience of therapeutic effects: results of a web-based questionnaire survey. 2015 Br. J. Dermatol. pmid:25421804